FOXO3 and diabetes mellitus: ALDH2 and its agonist Alda-1 are likely to offer protection by reversing diabetes or significant glucose-induced changes in AMPK and FOXO3a signaling, en route to improved autophagy, cardiac geometry, and mechanical function.